Previous close | 227.56 |
Open | 228.31 |
Bid | 224.19 x 1100 |
Ask | 233.96 x 800 |
Day's range | 227.02 - 234.66 |
52-week range | 195.47 - 254.00 |
Volume | |
Avg. volume | 510,317 |
Market cap | 23.012B |
Beta (5Y monthly) | 0.83 |
PE ratio (TTM) | 41.94 |
EPS (TTM) | 5.55 |
Earnings date | 06 Aug 2024 |
Forward dividend & yield | 2.08 (0.91%) |
Ex-dividend date | 12 Jun 2024 |
1y target est | 243.49 |
Key Insights STERIS to hold its Annual General Meeting on 1st of August Salary of US$1.03m is part of CEO Dan...
DUBLIN, IRELAND, July 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 first quarter financial results at 9:00 a.m. ET on August 7, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing financial result
STERIS' (STE) first-quarter fiscal 2025 results are likely to reflect the positives of the normalization of the Healthcare backlog, along with a core focus on pharma and MedTech.